CrownBio เปิดตัวโมเดลการค้นคว้ายาสร้างภูมิคุ้มกันบำบัดมะเร็งในมนุษย์แบบใหม่

NEXT STORY
TiGenix: Publication of prospectus and response memorandum for Takeda takeover bid commencing on April 30, 2018
PREV STORY
Vical Announces News Release and Conference Call Schedule for First Quarter 2018 Financial Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Hemispherx Provides an Update to Stockholders Highlighting Cancer Focus and $10 Million Booked Since Start of Year Will Support Increased Production of Ampligen for Immuno-Oncology Clinical Trials

ORLANDO, Fla., May 02, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American:HEB) would ...

author_avatar
NASDAQ Market News

NAESP Statement of Support for the STOP School Violence Act of 2018

Alexandria, Va., March 06, 2018 (GLOBE NEWSWIRE) -- The National Association of Elementary School ...

author_avatar
NASDAQ Market News

Aleafia Health Completes Strategic Investment in Australia’s CannaPacific Pty Limited

Global Expansion Underway with 10% Equity Investment in Licensed Cannabis Cultivator CannaPacific among Australia’s ...

author_avatar
NASDAQ Market News